Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective?

Per Winkel, Jørgen Hilden, Jørgen Fischer Hansen, Per Rossen Hildebrandt, Jens Kastrup, Hans Jørn Kolmos, Erik Kjøller, Christian M Jespersen, Christian Gluud, Gorm Boje Jensen, CLARICOR Trial Group

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    26 Citationer (Scopus)

    Abstract

    To elucidate potential mechanisms for the clarithromycin-induced excess mortality observed in the CLARICOR trial during 2.6 year follow-up of patients with stable coronary artery disease.
    OriginalsprogEngelsk
    TidsskriftCardiology
    Vol/bind118
    Udgave nummer1
    Sider (fra-til)63-7
    Antal sider5
    ISSN0008-6312
    DOI
    StatusUdgivet - 2011

    Citationsformater